Odonate Therapeutics Inc (ODT)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current ODT market cap is 16.38M. The company's latest EPS is USD 0.5008 and P/E is 2.24.
| Quarter End | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -33.82M | -27.54M | -14.02M | 1.4M | -438k |
| Net Income | -33.77M | -22.02M | -14M | 1.47M | 4.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -114.93M | -127.43M | -68.49M | -3.92M | -817k |
| Net Income | -111.83M | -126.35M | -68.32M | 42.94M | 7.33M |
| Quarter End | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 142.88M | 118.57M | 105.77M | 79M | 103.73M |
| Total Liabilities | 37.58M | 33.95M | 34.4M | 19.73M | 2.88M |
| Total Equity | 105.3M | 84.63M | 71.37M | 59.26M | 100.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 188.83M | 167.89M | 79M | 103.73M | 110.45M |
| Total Liabilities | 26.53M | 31.74M | 19.73M | 2.88M | 2.33M |
| Total Equity | 162.3M | 136.15M | 59.26M | 100.85M | 108.12M |
| Quarter End | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Dec 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -24.91M | -47.94M | -63.04M | -75.73M | 1.8M |
| Investing | -21k | -26k | -26k | -26k | -58.35M |
| Financing | 825k | 825k | 825k | -12.75M | -1.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -96.64M | -113.13M | -75.73M | 1.8M | 8.74M |
| Investing | -166k | -432k | -26k | -58.35M | 20.15M |
| Financing | 138.68M | 90.37M | -12.75M | -1.62M | -196k |
| Market Cap | 16.38M |
| Price to Earnings Ratio | 2.24 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.41 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 14.63M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (4.31%) |
| Company Name | Odonate Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.odonate.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
